ArticleFrontiers in oncology2024

Case report: Pathological complete response to neoadjuvant brigatinib in stage III non-small cell lung cancer with

Hayoung Seong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.